济南早射的病能治吗济南包茎什么样,济南怎么治疗敏感性早泄,济南男人阴茎不硬不挺怎么办,济南不让龟头敏感的方法,济南得了阳痿哪治,济南中医治前列腺,济南早泄得检查价格

SAN FRANCISCO, July 28 (Xinhua) -- Amazon announced Thursday that it had reached an agreement with NBC Universal to allow its members to view certain movies from Universal Pictures on-line through its movie streaming service.According to the on-line retail giant, Oscar-winning movies such as "Eternal Sunshine of the Spotless Mind," "Gosford Park" and "Elizabeth" as well as other favorites like "Notting Hill" and "Billy Elliot" are part of the pact.The movies will be available to Amazon Prime members through its streaming service Prime Instant Video. Amazon Prime is a membership program that gives subscribers discounts on shipping for a 79 U.S. dollar annual fee.In February, Amazon said it would offer Prime customers unlimited access to an on-line video library. Last Wednesday, Amazon announced an accord with CBS that expanded the video library to more than 8,000 movies and TV shows. It said Thursday that the NBC deal will bring the number to more than 9,000.With the CBS, NBC Universal deals, Amazon steps up its rivalry against other movie streaming services, especially Netflix, a popular on-line and mail-order movie rental company which just boosted prices by 60 percent for some subscribers. Analysts said Amazon is trying to make the pitch to those customers who are disappointed with Netflix.In a second-quarter earnings letter to investors distributed on Monday, Netflix CEO Reed Hastings said Netflix had more than 24.6 million subscribers in the U.S. at the end of June and vastly more streaming content than its competitors."We haven't detected an impact on our business from Amazon Prime," he noted.

New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world. Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."

WASHINGTON, Sept. 14 (Xinhua) -- Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published Wednesday in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.Led by Yale Professor Hugh Taylor, the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three- week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.Taylor said in a statement that the next step in the research will be to verify how long this treatment remains effective.

BERLIN, June 8 (Xinhua) -- German health minister Daniel Bahr expressed cautious hope Wednesday for an end to the wave of E. coli infections as authorities reported two more deaths and more than 300 new cases."I can't give an all-clear, but after the analysis of the latest data we have reasons for hope, as the number of new infections is continuously dropping," Bahr told local public television ARD before an emergency meeting in Berlin with European Union Health Commissioner John Dalli."Unfortunately, there will be new cases and more deaths have to be expected, but overall new infections are clearly going down," he said.On the same day, Germany's national disease control center, the Robert Koch Institute, said the number of reported cases in Germany had risen by more than 300 to 2,648. Nearly 700 of those affected have been taken to hospital with a serious complication that can cause kidney failure.The Institute did not fully support Bahr's optimism. It said there was a declining trend in new cases but added it was not clear whether this was because the outbreak was truly waning or because consumers were staying away from the raw vegetables believed to be the source of the E. coli.The German government has faced increasing criticism from abroad and at home over its dealing with the crisis. It was twice wrong in naming the source of the outbreak and it has been criticized for a lack of coordination between research institutes.Dalli was quoted by local daily Die Welt as saying, "we have to rely on the experience and expertise across Europe, and even outside Europe."The Max Planck Institute for Infection Biology in Berlin also called for a federal government representative to coordinate the various government agencies dealing with the disease to eliminate mixed messages.

BEIJING, May 31 (Xinhuanet) -- European anti-trust regulators Monday launched in-depth probes into takeover bids for two Asian companies by two American peers in the computer hard disk drive sector, media reports said Tuesday.U.S.-based Seagate Technology has said it wants to buy Samsung Electronics Co's loss-making hard disk drive unit for 1.4 billion U.S. dollars -- a deal that will give Seagate access to Samsung's NAND-type flash chips for its solid-state drive products.Western Digital plans to purchase Hitachi Ltd's hard disk drive business for 4.3 billion dollars to give it an edge in developing next-generation storage technology.The two planned acquisitions in a sector with just five manufacturers worldwide have raised concerns in Brussels, the European Commission said."Hard drives are the backbone of the digital economy," said EU competition commissioner Joaquin Almunia in announcing the investigation."The sector has already experienced significant consolidation and the proposed acquisitions will further reduce competition."Brussels officials have until Oct. 10 to decide what action if any they will take.